Refreshing results…
Receptor-interacting protein kinase 2 is an immunotherapy target in pancreatic cancer
UploadFungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer
UploadTelomere dysfunction activates YAP1 to drive tissue inflammation
Download from www.nature.comKRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer
UploadMissing publications? Search for publications with a matching author name.